Nicolas Cloarec
Laboratoire Informatique d'Avignon(FR)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, RNA modifications and cancer, Lung Cancer Research Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)(2020)164 cited
- → Immunotherapy for cancer in people living with HIV(2019)72 cited
- → PD-1 blockade in HIV-infected patients with lung cancer: a new challenge or already a strategy?(2018)34 cited
- → Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study(2021)34 cited
- → LBA85 REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer(2020)25 cited
- → Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial(2024)24 cited
- → Real-World efficacy and safety of combination nivolumab plus ipilimumab for Untreated, Unresectable, pleural Mesothelioma: The Meso-Immune (GFPC 04–2021) trial(2024)18 cited
- → EORTC-SPECTA Arcagen study, comprehensive genomic profiling and treatment adaptation of rare thoracic cancers(2024)16 cited
- → La péricardite : une manifestation de la maladie de Horton(2007)15 cited
- → Efficacy and safety results from neopembrov study, a randomized phase II trial of neoadjuvant chemotherapy (CT) with or without pembrolizumab (P) followed by interval debulking surgery and standard systemic therapy ± P for advanced high-grade serous carcinoma (HGSC): A GINECO study.(2021)12 cited